
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
DUBLIN, Feb. 05, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...
DUBLIN, Feb. 03, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.1 | -26.5763418447 | 19.19 | 19.19 | 12.04 | 1788639 | 14.9211598 | CS |
4 | 5.67 | 67.3396674584 | 8.42 | 20.5 | 8.021 | 1126286 | 16.19591922 | CS |
12 | 4.61 | 48.6286919831 | 9.48 | 20.5 | 6.72 | 419970 | 15.24224957 | CS |
26 | 4.08 | 40.7592407592 | 10.01 | 20.5 | 6 | 214324 | 14.26563103 | CS |
52 | 5.89 | 71.8292682927 | 8.2 | 20.5 | 6 | 148691 | 13.25833261 | CS |
156 | -4.47 | -24.0840517241 | 18.56 | 21.32 | 5.05 | 97445 | 11.87396608 | CS |
260 | -7.91 | -35.9545454545 | 22 | 30.43 | 5.05 | 102109 | 13.91296799 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約